Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol‐Associated Liver Disease
Liver International · 2026-12 · 46 (12)
DOI: 10.1111/liv.70930 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 31.10.2026. Verfasst von Gonzalo Pizarro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bradford Hill Clinical Research Center, Santiago, Chile. Hauptthemen laut MEDLINE: Liver Neoplasms, Liver Diseases, Alcoholic, Carcinoma, Hepatocellular, Alcoholism. Die Arbeit nennt 121 Literaturangaben. Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Excessive alcohol consumption is a significant global health concern, causing over 200 adverse health outcomes, including liver disease, cardiovascular disease, neuropsychiatric disorders, and malignancies. Among these, alcohol‐related liver disease (ALD) stands out as a leading contributor to cirrhosis and hepatocellular carcinoma (HCC) worldwide. Moreover, alcohol accounts for 27% of deaths from cirrhosis and chronic liver disease, with 30% of HCC‐related mortality attributed to alcohol use. Despite its severity, abstinence from alcohol markedly improves survival, even in advanced stages of ALD, highlighting the centrality of cessation efforts in disease management. HCC represents a major global health challenge, especially in individuals with ALD. Unfortunately, HCC often presents at an advanced stage, limiting treatment efficacy and resulting in a dismal 5‐year survival rate of 3.3%. Beyond HCC, alcohol use is linked to an elevated risk of other malignancies, such as cancers of the oral cavity, pharynx, larynx, oesophagus (squamous cell), liver (hepatocellular), colorectum, and female breast; compounding the disease burden. This review explores the intricate relationship between alcohol exposure, primary liver cancer, and other alcohol‐related malignancies. It highlights the pathophysiological mechanisms, epidemiological trends, and the importance of alcohol abstinence in mitigating disease progression. Future research must focus on innovative approaches to improve prevention, surveillance, diagnosis, and treatment in this high‐risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bradford Hill Clinical Research Center, Santiago, Chile.
- Hospital Sótero del Río, Santiago, Chile.
- Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
- MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, California, USA.
ORCID-Profile: Gonzalo Pizarro, Bastian Alcayaga, Kaanthi Rama, Jaime González-Montero, Marco Arrese, Juan Pablo Arab, Luis Antonio Díaz
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
Zitieren
APA
Pizarro, G., Alcayaga, B., Rama, K., González-Montero, J., Arrese, M., Arab, J. P., & Díaz, L. A. (2026). Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol‐Associated Liver Disease. Liver International, 46(12). https://doi.org/10.1111/liv.70930
Vancouver
Pizarro G, Alcayaga B, Rama K, González-Montero J, Arrese M, Arab JP, et al. Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol‐Associated Liver Disease. Liver International. 2026;46(12). doi:10.1111/liv.70930
BibTeX
@article{Pizarro2026,
author = {Pizarro, Gonzalo and Alcayaga, Bastian and Rama, Kaanthi and González-Montero, Jaime and Arrese, Marco and Arab, Juan Pablo and Díaz, Luis Antonio},
title = {Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol‐Associated Liver Disease},
journal = {Liver International},
year = {2026},
volume = {46},
number = {12},
doi = {10.1111/liv.70930}
}
EUVIMED